Neonatal surfactant therapy--where do we go from here?

Editorial

R J Martin. J Pediatr. 1991 Apr.

. 1991 Apr;118(4 Pt 1):555-6.

doi: 10.1016/s0022-3476(05)83376-1.

No abstract available

Comment on

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA, Hallman M, Berry C, Pohjavuori M, Edwards DK 3rd, Jaaskelainen J, Grafe MR, Vaucher Y, Wozniak P, Heldt G, et al. Merritt TA, et al. J Pediatr. 1991 Apr;118(4 Pt 1):581-94. doi: 10.1016/s0022-3476(05)83387-6. J Pediatr. 1991. PMID: 2007937 Clinical Trial.
Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Long W, et al. J Pediatr. 1991 Apr;118(4 Pt 1):595-605. doi: 10.1016/s0022-3476(05)83388-8. J Pediatr. 1991. PMID: 2007938 Clinical Trial.